APA (7th ed.) Citation

Isabel Elías, Itziar Oyagüez, Luis Antonio Alvarez-Sala, Fernando García-Bragadoa, Andrés Navarro, Paloma González, . . . Javier Soto. (2016). Cost-effectiveness analysis of apixaban compared to low-molecularweight heparins and vitamin k antagonists for treatment and secondary prevention of venous thromboembolism. Elsevier.

Chicago Style (17th ed.) Citation

Isabel Elías, Itziar Oyagüez, Luis Antonio Alvarez-Sala, Fernando García-Bragadoa, Andrés Navarro, Paloma González, Fernando de Andrés-Nogales, and Javier Soto. Cost-effectiveness Analysis of Apixaban Compared to Low-molecularweight Heparins and Vitamin K Antagonists for Treatment and Secondary Prevention of Venous Thromboembolism. Elsevier, 2016.

MLA (9th ed.) Citation

Isabel Elías, et al. Cost-effectiveness Analysis of Apixaban Compared to Low-molecularweight Heparins and Vitamin K Antagonists for Treatment and Secondary Prevention of Venous Thromboembolism. Elsevier, 2016.